You are viewing an incomplete version of our website. Please click to reload the website as full version.

Browse our anti-IFNA1 (IFNA1) Antibodies

Full name:
anti-Interferon, alpha 1 Antibodies (IFNA1)
On are 39 Interferon, alpha 1 (IFNA1) Antibodies from 2 different suppliers available. Additionally we are shipping IFNA1 Proteins (10) and and many more products for this protein. A total of 52 IFNA1 products are currently listed.
Ifa1, IFL, IFN, IFN-ALPHA, IFN-ALPHA-1, IFN-alpha1, IFN-alphaD, IFN1@, IFNA1, IFNA13, IFNA@
list all antibodies Gene Name GeneID UniProt
IFNA1 15962 P01572
IFNA1 298210 P05011
IFNA1 3439 P01562

Show all species

Show all synonyms

Most Popular Reactivities for anti-IFNA1 (IFNA1) Antibodies

Select your species and application

anti-Mouse (Murine) IFNA1 Antibodies:

anti-Rat (Rattus) IFNA1 Antibodies:

anti-Human IFNA1 Antibodies:

All available anti-IFNA1 Antibodies

Go to our pre-filtered search.

More Antibodies against IFNA1 Interaction Partners

Atlantic Salmon (Salmo salar) Interferon, alpha 1 (IFNA1) interaction partners

  1. IFNa (show IFNA Antibodies) is the main IFN subtype induced through salmon RIG-I (show DDX58 Antibodies)/viral RNA receptor MDA5 (show IFIH1 Antibodies) pathway in lymphoid tissues.

Mouse (Murine) Interferon, alpha 1 (IFNA1) interaction partners

  1. IL-12 (show IL12A Antibodies) and IFN-alpha (show IFNA Antibodies) differentially program CD8 (show CD8A Antibodies) T cells to re-express distinct levels of PD-1 (show PDCD1 Antibodies) upon re-encountering Ag, resulting in IL-12 (show IL12A Antibodies)-stimulated cells being less susceptible to exhaustion in the face of sustained tumor Ag.

  2. The expansion of CD8 (show CD8A Antibodies) T cells depends on type I IFN, type I IFN and IL-12 (show IL12A Antibodies) or is largely independent of the two cytokines.

  3. A spontaneous genomic duplication and frameshift mutation in the guanine exchange factor dedicator of cytokinesis 2 (Dock2 (show DOCK2 Antibodies)) that has arisen in at least a subset of circulating Irf5 (show IRF5 Antibodies)(-/-) mice and inadvertently been bred to homozygosity.

  4. Knockdown of endogenous guanylate binding protein (GBP)4 (show GBP4 Antibodies) increases IRF7 (show IRF7 Antibodies)-mediated IFN-alpha (show IFNA Antibodies) production, whereas overexpression of GBP4 (show GBP4 Antibodies) has the opposite effect.

  5. Data show that similar T cell expansion and serum IgG responses were observed in adenovirus (Adv (show AVIL Antibodies))-IFN-treated WT and BAFF (show TNFSF13B Antibodies)-deficient mice despite their disparate pathological and clinical responses.

  6. Studies in both mice and humans have demonstrated a role for IFN-alpha (show IFNA Antibodies)/beta in directly influencing the fate of both CD4 (show CD4 Antibodies)(+) and CD8 (show CD8A Antibodies)(+) T cells during the initial phases of antigen recognition.

  7. IFN-alpha (show IFNA Antibodies) enhances both the induction and maintenance of programmed cell death (PD)-1 (show PDCD1 Antibodies) expression on T cell receptor-engaged primary mouse T cells through association of IFN-responsive factor 9 (IRF9 (show IRF9 Antibodies)) with the IFN stimulation response element.

  8. This article reports the production of interferon alpha (show IFNA Antibodies)/beta (IFN-alpha (show IFNA Antibodies)/beta) by SJL/J mouse brain astrocyte cultures infected with Theiler's murine encephalomyelitis virus (TMEV).

  9. TLR ligands facilitate antibody response by inducing type I interferon (show IFNA Antibodies) (IFN), which in turn elicits rapid and significant amounts of antigen-specific IgG2c.

  10. These results demonstrate that mouse hepatitis virus is recognized by both RIG-I (show DDX58 Antibodies) and MDA5 (show IFIH1 Antibodies) and induces IFN-alpha (show IFNA Antibodies)/beta through the activation of the IRF-3 (show IRF3 Antibodies) signaling pathway.

Human Interferon, alpha 1 (IFNA1) interaction partners

  1. IL-2 (show IL2 Antibodies) therapy should be used as a first- or second-line therapy following IFN-a (show IFNA6 Antibodies) therapy. IL-2 (show IL2 Antibodies) may have a lower response if it is used after molecular-targeted therapy or other treatments

  2. results show that IFNA1 rs1332190 and IFNA17 (show IFNa17 Antibodies) rs9298814 SNPs may play an important role in Crimean-Congo hemorrhagic fever susceptibility

  3. Interferon-alpha (show IFNA Antibodies)-induced TRIM22 (show TRIM22 Antibodies) interrupts hepatitis c virus replication by ubiquitinating NS5A.

  4. our data indicate that by targeting PTP1B (show PTPN1 Antibodies), miR (show MLXIP Antibodies)-744 plays a feed-forward role in regulating type I IFN signaling pathway.

  5. the findings demonstrate that treatment with anti-CD20 (show MS4A1 Antibodies)-hIFNalpha reverses resistance of B-NHL (show RTEL1 Antibodies)

  6. NS of severe fever with thrombocytopenia syndrome virus inhibited the activity of IFN-alpha1, IFN-beta (show IFNB1 Antibodies), IFN-lambda1 and IFN-lambda2 (show IL28A Antibodies) through inhibition of STAT1 (show STAT1 Antibodies) phosphorylation.

  7. interferon (IFN)-alpha (show IFNA Antibodies), weakens activation of the anti-bacterial interleukin (IL)-1 (show IL1A Antibodies)/IL-22 (show IL22 Antibodies) axis in human peripheral blood mononuclear cells exposed to viable B. burgdorferi

  8. Shp-2 (show PTPN11 Antibodies) contributes to the control of respiratory syncytial virus replication and progeny production in pulmonary alveolar epithelial cells by interfering with IFN-alpha (show IFNA Antibodies)-induced Jak (show JAK3 Antibodies)/Stat1 (show STAT1 Antibodies) pathway activation

  9. Interferon (show IFNA Antibodies) alfa induces high response rates with low toxicity in patients with polycythemia vera (show IGF2BP3 Antibodies).

  10. This study suggests that suppression of miR (show MLXIP Antibodies)-122 induced by hepatitis B virus infection, leads to the inactivation of interferon (show IFNA Antibodies) expression, which in turn enhances hepatitis B virus replication.

Pig (Porcine) Interferon, alpha 1 (IFNA1) interaction partners

  1. Amino acid residues in the N-terminal domain of Npro are involved in the stability of Npro, in interaction of Npro with IRF-3 (show IRF3 Antibodies) and subsequent degradation of IRF-3 (show IRF3 Antibodies), leading to downregulation of IFN-alpha (show IFNA Antibodies)/beta production.

  2. Pregnane X receptor is required for interferon-alpha-mediated CYP3A29 expression, and its expression before CYP3A29.

  3. Overall, data provide evidence for the possible role of PI3K in the activation of the transcription of IFN-alpha (show IFNA Antibodies)/beta by PRRSV; study concludes that PRRSV inhibits the induction of IFN-alpha (show IFNA Antibodies) in monocyte-derived dendritic cells by as yet undefined post-transcriptional mechanisms.

  4. Nsp1beta inhibits interferon-activated (show MNDA Antibodies) STAT1 (show STAT1 Antibodies)/STAT2 (show STAT2 Antibodies) signal transduction by inducing karyopherin-alpha1 degradation.

  5. Expression of Mx protein (show MX2 Antibodies) and interferon-alpha (IFN-alpha (show IFNA Antibodies)) was examined by immunohistochemistry in pigs experimentally infected with swine influenza virus.

  6. Foot-and-Mouth Disease Virus inhibits IFN-alpha (show IFNA Antibodies) expression in infected cells by blocking cap-dependent translation.

IFNA1 Antigen Profile

Antigen Summary

The protein encoded by this gene is produced by macrophages and has antiviral activity. This gene is intronless and the encoded protein is secreted.

Alternative names and synonyms associated with IFNA1

  • interferon alpha 1 (IFNA1) antibody
  • interferon-alpha-1 (IFNA1) antibody
  • interferon alpha 1 (ifna1) antibody
  • interferon, alpha 13 (IFNA13) antibody
  • interferon alpha 1 (Ifna1) antibody
  • interferon alpha-1-like (LOC100629951) antibody
  • Interferon alpha-1-like (LOC616272) antibody
  • interferon-alpha 1 (Ifna1) antibody
  • interferon, alpha 1 (IFNA1) antibody
  • Ifa1 antibody
  • IFL antibody
  • IFN antibody
  • IFN-ALPHA antibody
  • IFN-ALPHA-1 antibody
  • IFN-alpha1 antibody
  • IFN-alphaD antibody
  • IFN1@ antibody
  • IFNA1 antibody
  • IFNA13 antibody
  • IFNA@ antibody

Protein level used designations for IFNA1

interferon alpha-1/13 , interferon-alpha-1 , interferon alpha 1 , interferon-alpha-3 , interferon alpha 13 , IFN-alpha-1 , interferon alpha family gene 1 , interferon alpha-1 , IFN-alpha 1 , interferon-alpha 1 , IFN-alpha 1b , IFN-alpha-1/13 , interferon alpha 1b , interferon alpha-D , interferon-alpha1 , leIF D , IFN-alpha-6 , interferon-alpha-6

493765 Felis catus
100053022 Equus caballus
100137019 Salmo salar
493654 Felis catus
15962 Mus musculus
100629951 Equus caballus
616272 Bos taurus
298210 Rattus norvegicus
3439 Homo sapiens
397686 Sus scrofa
Selected quality suppliers for anti-IFNA1 (IFNA1) Antibodies
Did you look for something else?